We are pleased to present Dr Chris Stowers Sr Director of Biotechnology at Royal DSM to speak on 
Deploying Biotechnology at DSM to Address Global Challenges in Nutrition, Health and Sustainability

Abstract

At Royal DSM, we see biotechnology as a key solution to address climate change, resource scarcity and circularity.  Building on 150 years of expertise, today DSM is a global, purpose-led leader in biotechnology with R&D centers and manufacturing sites around the world.   With over 500 scientists working in biotechnology R&D globally across eight different locations, we have the gamut of biotech capabilities needed to rapidly discover and scale new bioprocesses.  We will review those capabilities in this presentation and a few case studies will be shared on how these capabilities were deployed to deliver new products to the marketplace that improve sustainability, nutrition and health.  In particular, we will discuss how DSM has recently delivered new lipids and vitamins to the marketplace that dramatically reduce our environmental footprint and improve sustainability.

Bio

 

Dr Chris Stowers completed his bachelor’s in Biochemical Engineering at the University of Alabama in Huntsville, and obtained his PhD in Biochemical Engineering at Vanderbilt University. He started at Dow Agroscience, which eventually became Corteva, in 2008 as a senior biochemical engineer. He moved up to oversee a team of scientists and engineers working to develop and scale fermentation processes for insecticides, fungicides and biochemicals. He was promoted multiple times, and in 2019, his responsibilities expanded to lead the bioengineering and bioprocessing R&D departments. Then in April 2021, he took the post at DSM, where he leads a team of scientists and engineers responsible for developing sustainable processes for the production of nutritional products such as vitamins, carotenoids and lipids. Previously he led a team at Corteva Agriscience responsible for improving the company’s natural products for the insecticides and fungicides markets. In 2021, he was listed in the Forty under 40 most influential people by the Indianapolis Business Journal.

About AIBN Seminar Series

The AIBN Seminar series showcases a range of seminars across different topics and disciplines